UAB’s Jack Hasson has been named the 2017 Outstanding Clinician by the American Thoracic Society.
Three UAB investigators have received innovative research grants for lung diseases from the National Institutes of Health.
UAB’s Mark Dransfield has been elected to the American Society for Clinical Investigation, an honor society for physician-scientists who have made significant contributions to better understanding of human disease.
UAB has created the only comprehensive interventional pulmonary medicine program in Alabama to better diagnose and treat lung and chest diseases.
In another example of precision medicine, UAB researchers have used IPF patients own lung tissue to create models to determine the most effective medication for that patient.
A new national, multisite study, chaired by a UAB pulmonologist, shows that supplemental oxygen does not reduce mortality or hospitalization for COPD patients with moderately low levels of blood oxygen.

Exacerbations of COPD, particularly mild COPD, lead to a decline in lung function in smokers, according to new research from UAB.

Ben Branscomb, a pioneering physician and long-time UAB faculty member, was often called the father of pulmonary medicine.
Michelle Harris came to UAB on maximal life support, unsure if she would live after a rare multisystem autoimmune disease attacked her lungs. Now, she will go home with her eyes on upcoming prom and graduation.
UAB launches new clinic for primary ciliary dyskinesia, a rare, inherited respiratory disease.
UAB researchers probe basic molecular mechanisms that lead to the lung scarring of pulmonary fibrosis, a lethal disorder.
UAB researchers led a team that discovered that a smoking-related condition called expiratory airway collapse — often thought inconsequential — is associated with lung disease.
Best of 2015 2Telemedicine helps UAB take pulmonary rehabilitation into the home via smartphone technology, in an effort to reduce hospital readmissions from COPD.
The Cystic Fibrosis Foundation recognizes UAB’s Adult CF Program with Quality Care Award.
Macrophage cells require agility to scavenge and digest dead cells and prevent an immune response to self. In lupus, the macrophages lose that agility.
A UAB researchers suggests that autoimmune disease therapy may be an effective treatment for idiopathic pulmonary fibrosis
An experimental lung-volume-reduction procedure using one-way valves shows promise for a UAB patient.
UAB’s William Bailey honored by his alma mater with a lifetime achievement award for 50 years of exemplary service in medicine.
UAB was part of a promising international study of a combination therapy for patients with the most common cystic fibrosis mutation.
UAB is implanting one-way valves in patients with severe emphysema in an effort to reduce their overall lung volume, which improves lung function.
Page 1 of 3
Back to Top